﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Medical Journal of Tabriz University of Medical Sciences</JournalTitle>
      <Issn>2783-2031</Issn>
      <Volume>29</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2007</Year>
        <Month>03</Month>
        <DAY>22</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Clinical Efficacy of Salbutamol Spray in Treatment of Bronchiolitis</ArticleTitle>
    <FirstPage>27</FirstPage>
    <LastPage>29</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>BILAN N</LastName>
      </Author>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>SAIIED SADRY N</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2010</Year>
        <Month>05</Month>
        <Day>22</Day>
      </PubDate>
    </History>
    <Abstract>Background and Objectives: Bronchiolitis is the most common lower respiratory tract infection during first year of life and the cause of about 1% of infant’s hospitalizations. The treatment is mainly supportive but many studies have emphasized the role of bronchodilators. This study was aimed to show the efficacy of salbutamol spray. Materials and Methods: In a Randomized controlled trial, 100 patients with bronchiolitis were randomly divided in to two groups (50 patients to each). First group received salbutamol spray (2 puffs via spacer every 4 hours)and second group nebulized 1/1000 epinephrine (0.2 mg/kg plus 3.5cc solin every 4 hours). Inclusion criteria: infants attueage of 2-12 months with bronchiolitis were diagnosed as lower respiratory tract infection accompanied by fever, rhinitis, tachypnea, wheezing, and dyspnea. Exclusion criteria: patients with cardiac or pulmonary problems, history of bronchodilator the rap or hospital admission with wheezing, history of corticosteroid consumption and ICU admission due to sever bronchiolitis. Results: The age and the gender differences were not significant (p=0.2 and 0.6 respectively). Outcome indicators such as length of hospital stay and the time needed to restart normal nutrition had no significant differences (p=0.1 and p=0.47 respectively). Conclusion: Considering feasibility of access and participation of parents in treatment and lack of significant differences between two groups, we suggest using salbutamol spray in treatment of bronchiolitis.</Abstract>
  </Article>
</ArticleSet>